Moderna, Inc. discovers and develops mRNA therapeutics and vaccines for various diseases. It has respiratory, latent, public health, and infectious disease vaccines. The company also offers systemic, cancer, intratumoral, rare disease, and pulmonary therapeutics. Moderna has strategic alliances with several companies, including AstraZeneca, Merck & Co., Vertex Pharmaceuticals, and Chiesi Farmaceutici. The company was founded in 2010 and is headquartered in Cambridge, Massachusetts. It changed its name from Moderna Therapeutics to Moderna, Inc. in August 2018.
| Indicator | Value |
|---|---|
| PER | 100.0 |
| EV/EBITDA | 100.0 |
| Price/Free Cash Flow' | 100.0 |
| ROIC | -% |
| Net Debt/EBITDA | 0.4 |